BIOMAT Database Logo BIOMAT Database Logo

Single- and multiple-dose pharmacokinetics of levovirin valinate hydrochloride (R1518) in healthy volunteers. 2005

Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Clinical Pharmacology, Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, CA 94304, USA.

R1518 is a valine ester prodrug of levovirin as an investigational new drug for the treatment of hepatitis C virus. Two phase 1, single- and multiple-dose studies were conducted to investigate the pharmacokinetics of R1518 in healthy volunteers. After oral dosing, R1518 was rapidly and exclusively converted to levovirin. Levovirin plasma concentrations peaked at 2 hours, with T(1/2) ranging from 6 to 8 hours. The T(1/2) of R1518 was less than 1 hour, with relative exposures (R1518/levovirin) less than 6%. A high-fat meal did not affect the pharmacokinetics. The female groups in both studies had higher plasma levels than males did due to age and renal function difference. An accumulation ratio of 1.3 to 1.5 was observed with the twice-daily regimen. About 75% to 90% of the levovirin equivalent dose was recovered in urine. Increase in exposure was slightly disproportionate to increase in dose. Significantly improved oral absorption of levovirin was achieved following administration of R1518.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009005 Monosaccharides Single chain carbohydrates that are the most basic units of CARBOHYDRATES. They are typically colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn. Monosaccharide,Simple Sugar,Simple Sugars,Sugar, Simple,Sugars, Simple
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
December 1998, Clinical pharmacology and therapeutics,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers.
January 1988, European journal of clinical pharmacology,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
July 2003, Anesthesia and analgesia,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Single-dose pharmacokinetics and safety of iptakalim hydrochloride in Chinese healthy volunteers.
March 2012, The Journal of pharmacy and pharmacology,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers.
January 1989, Antimicrobial agents and chemotherapy,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Single- and multiple-dose pharmacokinetics of sotalol hydrochloride in healthy cats.
February 2024, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Single- and multiple-dose pharmacokinetics of tofacitinib in healthy Chinese volunteers.
September 2015, Clinical pharmacology in drug development,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers.
January 1996, European journal of clinical pharmacology,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Single- and Multiple-Dose Milnacipran Pharmacokinetics in Healthy Han Chinese Volunteers.
July 2016, Clinical pharmacokinetics,
Yue Huang, and Susanne Ostrowitzki, and George Hill, and Mercidita Navarro, and Nancy Berger, and Paul Kopeck, and Cheng I Mau, and Tom Alfredson, and Ritu Lal
Single- and multiple-dose pharmacokinetics of inhaled indacaterol in healthy Chinese volunteers.
June 2015, European journal of drug metabolism and pharmacokinetics,
Copied contents to your clipboard!